Stay updated with breaking news from Arcellx Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) shares rose 5.8% during trading on Monday . The company traded as high as $54.37 and last traded at $53.71. Approximately 262,564 shares changed hands during trading, a decline of 42% from the average daily volume of 450,555 shares. The stock had previously closed at $50.78. Analyst Upgrades […]
Arcellx (NASDAQ:ACLX – Get Free Report) was upgraded by analysts at Evercore ISI to a “strong-buy” rating in a research report issued on Monday, Zacks.com reports. A number of other research analysts also recently commented on the company. Needham & Company LLC restated a “buy” rating and issued a $81.00 target price on shares of […]
-Contineum is focused on leading the Neuroscience, Inflammation and Immunology field- -Successful completion of Initial Public Offering with strong syndicate of existing and new investors- ...
Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) insider Christopher Heery sold 18,168 shares of Arcellx stock in a transaction that occurred on Wednesday, May 1st. The shares were sold at an average price of $51.33, for a total transaction of $932,563.44. Following the transaction, the insider now directly owns 8,938 shares in the company, valued […]
Arcellx, Inc. (NASDAQ:ACLX – Get Free Report) insider Christopher Heery sold 18,168 shares of the business’s stock in a transaction dated Wednesday, May 1st. The shares were sold at an average price of $51.33, for a total value of $932,563.44. Following the completion of the sale, the insider now owns 8,938 shares in the company, […]